This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Guangdong University of Technology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Jierui Huo
Introduction
Jierui Huo is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative methods of preparing novel crystal forms of medications. His work emphasizes safety, efficiency, and environmental friendliness in drug production.
Latest Patents
One of Jierui Huo's key patents is titled "Crystal form F of trelagliptin and preparation method thereof." This patent describes a method for preparing a novel crystal form F of trelagliptin. The process involves adding a mediating protein to trelagliptin to create a mixture, followed by applying mechanochemical action to transform the crystal form. This innovative preparation method does not require organic solvents, thereby eliminating the risk of solvent residue that could compromise medication safety. Additionally, it is less time-consuming than traditional solvent crystallization methods, making it suitable for green industrial production. The method is characterized by its simplicity, high efficiency, safety, and environmental friendliness.
Career Highlights
Jierui Huo is affiliated with the Guangdong University of Technology, where he continues to advance research in pharmaceutical sciences. His work has garnered attention for its practical applications in improving drug formulation processes.
Collaborations
Jierui Huo has collaborated with notable colleagues, including Kailin Xu and Jianping Wang. Their combined expertise contributes to the innovative research environment at the Guangdong University of Technology.
Conclusion
Jierui Huo's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to enhancing medication safety and production efficiency. His work is a testament to the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile